# Pleconaril Enteroviral Sepsis Syndrome

> **NCT00031512** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 61 (actual)

## Conditions studied

- Enterovirus Infection

## Interventions

- **OTHER:** Placebo
- **DRUG:** Pleconaril

## Key facts

- **NCT ID:** NCT00031512
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06-27
- **Primary completion:** 2010-09-22
- **Final completion:** 2012-09-15
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00031512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00031512, "Pleconaril Enteroviral Sepsis Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00031512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*